Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B2 | P19099 | 1/20 | 0.42 |
| ▸ | ESR2 | Q92731 | 7/20 | 0.41 |
| ▸ | HTT | P42858 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.39 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.39 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.39 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | NOTUM | Q6P988 | 2/20 | 0.39 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.38 |
| ▸ | ESR1 | P03372 | 5/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5543159 | 1.00 | CYP11B2 (0.42) | CYP11B2ESR2HTTLMNASLC18A3 | |
| SCHEMBL22833 | 1.00 | CYP11B2 (0.42) | CYP11B2ESR2HTTLMNASLC18A3 | |
| SCHEMBL2911926 | 1.00 | CYP11B2 (0.42) | CYP11B2ESR2HTTLMNASLC18A3 | |
| SCHEMBL27452122 | 0.98 | CYP11B2 (0.41) | CYP11B2ESR2HTTLMNASLC18A3 | |
| SCHEMBL21538 | 0.97 | ESR2 (0.42) | CYP11B2ESR2HTTLMNASLC18A3 | |
| Fluoromethane SCHEMBL28164137 | 0.93 | CYP11B2 (0.38) | CYP11B2ESR2HTTLMNASLC18A3 | |
| SCHEMBL43455 | 0.92 | ESR2 (0.47) | CYP11B2ESR2SLC18A3HDAC1HDAC8 | |
| SCHEMBL29099563 | 0.91 | CYP11B2 (0.37) | CYP11B2ESR2HTTLMNASLC18A3 | |
| SCHEMBL6578876 | 0.89 | POLB (0.46) | ESR2SLC18A3POLBESR1CYP2D6 | |
| SCHEMBL22929 | 0.89 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 93 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0179015-B1 | 7-(ARYLOXY)-2-NAPHTHOXYALKANECARBOXYLIC ACID DERIVATIVES, PROCESSES FOR THE PREPARATION OF THESE COMPOUNDS, AS WELL AS AGENTS HAVING HERBICIDAL ACTIVITY CONTAINING THESE COMPOUNDS | SCHERING AKTIENGESELLSCHAFT (DE) | 1988-04-13 | — | — | EP | claimed |
| US-4089972-A | Organotin sulfinates as insecticides and acaricides | UNIROYAL, INC. (US) | 1978-05-16 | — | — | US | claimed |
| CN-115989233-A | Ligand compound, organic chromium compound and catalyst system comprising same | 株式会社LG化学 | 2023-04-18 | — | — | CN | disclosed |
| US-20220396574-A1 | LIGHT-EMITTING DEVICE, DISPLAY DEVICE, ELECTRONIC DEVICE, ORGANIC COMPOUND, AND LIGHTING DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2022-12-15 | — | — | US | disclosed |
| CN-109982995-B | Preparation of amino acids and amino acid derivatives | 优美科股份公司及两合公司 | 2022-09-30 | — | — | CN | disclosed |
| CN-114652735-A | Compounds and methods for promoting myelination | 凯斯西储大学 | 2022-06-24 | — | — | CN | disclosed |
| CN-109862963-B | Synthesis and characterization of Ru alkylidene complexes | 优美科股份公司及两合公司 | 2022-05-24 | — | — | CN | disclosed |
| CN-109641198-B | Synthesis and characterization of metathesis catalysts | 优美科股份公司及两合公司 | 2022-04-12 | — | — | CN | disclosed |
| CN-114206889-A | Novel synthesis of Z-selective olefin metathesis catalysts | 加利福尼亚技术学院 | 2022-03-18 | — | — | CN | disclosed |
| CN-114106057-A | Synthesis and characterization of Ru alkylidene complexes | 优美科股份公司及两合公司 | 2022-03-01 | — | — | CN | disclosed |
| CN-113924295-A | Kinase inhibitors | 英矽智能科技知识产权有限公司 | 2022-01-11 | — | — | CN | disclosed |
| US-4371646-A | 2,6-Di-tertiary butyl phenyl phosphites and synthetic resin compositions having enhanced stability to heat and light | ADEKA ARGUS CHEMICAL CO. LTD. (JP) | 1983-02-01 | — | — | US | disclosed |
| US-4362830-A | Hindered bis-phenol phenyl phosphites and synthetic resin compositions having enhanced stability to heat and light | ADEKA ARGUS CHEMICAL CO., LTD. (JP) | 1982-12-07 | — | — | US | disclosed |
| EP-0038876-A1 | 2,6-Di-tertiary butyl phenyl pentaerythritol spiro bis-phosphites enhancing the stability to heat and light of synthetic resins, stabilizer compositions comprising phenolic antioxidants and such phosphites, and synthetic resin compositions containing the same | ADEKA ARGUS CHEMICAL CO., Ltd. (JP) | 1981-11-04 | — | — | EP | disclosed |
| EP-0033395-A2 | 2,6-Di-tertiary butyl phenyl phosphites and synthetic resin compositions containing these phosphites | ADEKA ARGUS CHEMICAL CO., Ltd. (JP) | 1981-08-12 | — | — | EP | disclosed |
| EP-0032681-A2 | Hindered bis-phenol phenyl phosphites and synthetic resin compositions having enhanced stability to heat and light | ADEKA ARGUS CHEMICAL CO., Ltd. (JP) | 1981-07-29 | — | — | EP | disclosed |
| US-4140681-A | ANTICOAGULANTS | MITSUBISHI CHEMICAL INDUSTRIES, LIMITED (JP) | 1979-02-20 | — | — | US | disclosed |
| US-4131673-A | INHIBITION AND SUPPRESSION OF THROMBOSIS IN MAMMALS | MITSUBISHI CHEMICAL INDUSTRIES, LIMITED (JP) | 1978-12-26 | — | — | US | disclosed |
| US-4125604-A | PEPTIDES, ANTITHROMBOSIS | MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JP) | 1978-11-14 | — | — | US | disclosed |
| US-4097591-A | ANTITHROMBOSIS | MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JA) | 1978-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220396574-A1 | LIGHT-EMITTING DEVICE, DISPLAY DEVICE, ELECTRONIC DEVICE, ORGANIC COMPOUND, AND LIGHTING DEVICE | CRY1, CYP1A1, ARNT | CYP11B2 332/4885ESR2 85/4885HTT 1230/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.